期刊文献+

不同因素刺激DC对CD4^+CD25^+调节性T细胞的作用 被引量:1

The effect of different factors stimulated dendritic cells on the CD4^+CD25^+ regulatory T cells
下载PDF
导出
摘要 目的观察不同因素刺激下的DC分化及数量变化,对CD4+CD25+调节性T细胞的抑制作用。方法制备六味地黄丸含药血清,刺激树突状细胞;反复冻融法制备细胞抗原负载树突状细胞;将实验分为:DC与空白血清组、DC与胃癌细胞组、DC与含药血清组、DC与胃癌细胞和六味地黄丸含药血清联合作用组,将各组分别与淋巴细胞共培养,MTT法检测各组DC数量的变化,流式细胞仪检测DC对CD4+CD25+调节性T细胞的作用。结果在药物作用48 h含药血清浓度为15%时与空白血清组分别作用24、72 h相比,DC的吸光光度值能显著升高(P<0.05)。胃癌细胞与六味地黄丸共同作用组DC吸光光度值显著升高,DC吸光光度值升高对CD4+T细胞的增殖能力有明显调节作用,可降低CD4+T细胞中CD4+CD25+调节性T细胞的数量。结论胃癌细胞作为抗原负载DC,具有促进DC细胞增殖及分化的作用,并可增强CD4+T细胞的增殖能力和降低CD4+T细胞中Treg的数量,六味地黄丸具有辅助调节作用。 【Objective】The differentiation and changes of DC in the number of of different stimuli, inhibition of CD4+CD25+regulatory T cells.【Methods】Preparation of Six Ingredient Rehmannia Pill medicated serum, stimulation of dendritic cells; using repeated freezing and thawing method to prepare cell antigen loading dendritic cell;divided into four groups: DC with the blank serum group, DC group, DC and gastric cancer cell and medicated serum group, the combined effect of DC cells with gastric cancer and Six Ingredient Rehmannia Pill medicated serum group; each group co culture with lymphocyte respectively, changes in the number of DC was detected by MTT,using flow cytometry to detected DC and its effect on CD4+CD25+ regulatory T cells. 【Results】Effect of 48 h respectively roles in drug containing serum concentration is 15% and the blank serum group 24 h, 72 h than the DC photometric value can be increased significantly(P0.05). Gastric cancer cells and the six tastes glutinous rehmannia pill interaction group DC photometric values increased significantly, DC photometric values increased on CD4+ T cells proliferation ability has obvious adjustment function,which can reduce the number of CD4+CD25+ regulatory T cells in CD4+T cells. 【Conclusion】Gastric cancer cells as antigen loaded DC, has the function of promoting DCs proliferation and differentiation, and can enhance the CD4+T cell proliferation ability and reduce the amount of Treg in CD4+ T cells; the six tastes glutinous rehmannia pill has the auxiliary regulating function.
出处 《中国医学工程》 2015年第6期1-2,4,共3页 China Medical Engineering
基金 国家自然科学基金(81273980 81072969)
关键词 树突状细胞 CD4+CD25+调节性T细胞 抗原 六味地黄丸 dendritic cells CD4+CD25+ regulatory T cells antigy Liuwei Dihuang Pill
  • 相关文献

参考文献9

  • 1Molenaar R,Knippenberg M,Goverse G,et al.Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A[J].J Immunol,2011,186: 1934-1942.
  • 2Hall JA,Cannons JL,Grainger JR,et al.Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha[J].Immunity,2011,34:435-447.
  • 3Walter TL,Keiji S,Hide K,et al.Tumor-dendritic cell fusion as a basis for cancer Immunotherapy[J].Otolaryngolngy Head and Neck Surgery,2005,132(5):755-764.
  • 4Tao Yang,Ying Xiang,Yucheng Li,Jianghe Shao,Qiying Li,Huiqing Yu.Clinical study of co-treatment with DC-CIK cells for advanced solid carcinomas[J].The Chinese-German Journal of Clinical Oncology,2011,10(6):354-359. 被引量:4
  • 5Karen C,Galvin Lydia Dyck Nell A,Marshall Anna M,et al.Blocking Retinoic acid receptor- o enhances the efficacy of a dendritic cell vaccine against turnouts by supressing the induction of regulatory T cells[J].Cancer Immunol Immunther,2013,2:152-160.
  • 6骆云雅.DC瘤苗的研究新进展[J].中国肿瘤生物治疗杂志,2003,10(1):74-76. 被引量:2
  • 7Mule JJ.Tumor vaccine strategies that employ dendritic cells and tumor lysate: Experimental and clinical studies[J].Immunol Invest,2000,29(2): 127 - 129.
  • 8Jenne L,Arrighi JF,Jonuleit H,et al.Dendritic cells containing apoptotic cells prime human CD8+ T ceils for efficient tumor cell lysis[J].Cancer Res,2000,60:4446-4456.
  • 9Kuyler A,Stuhler G,Watden P,et al.Regression of human metastatic renal cell carcinoma after vaccine with tumor cell dendritic cell hybrids[J].Nat Med,2000,6:332-336.

二级参考文献22

  • 1应敏刚,郑秋红,陈奕贵,谢云青,龚福生,陈路川,吴君心,郑天荣.CIK与DC细胞联合治疗145例晚期恶性实体瘤[J].福建医科大学学报,2007,41(3):218-221. 被引量:19
  • 2[18]Nshioka Y, Hirao M, Robbins PD, et al. Induction of systemic and therapeutic antitumor using introtmoral injection of dendritic cells genetically modified to express IL-12[J]. Cancer Res,1999, 59(16): 4035-4041.
  • 3[19]Nishimura N, Nishioka Y, Shinohara T, et al. Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells[J]. J Immunol Methods, 2001, 253(1-2): 114-124.
  • 4[20]Viggo F, Van T, Peter P, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells[J]. Blood, 2001, 98(1): 45-56.
  • 5[1]Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer[J]. J Immunol, 2001, 166(1): 678-689.
  • 6[2]Peter B, Stefan W, Wolfram B, et al. Dendritic cells in cancer vaccines[J]. Exp Hematol, 2001, 29: 1247-1255.
  • 7[3]Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines[J]. Cell, 2001, 106(3): 255-258.
  • 8[4]Nina B.Processing and presentation of antigen by dendritic cells: Implications for vaccines[J]. Trends Mol Med, 2001, 7: 1154-1162.
  • 9[5]Ramadan G, Schmit RE, Schubert J. in vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA alone in serum-free medium[J]. Clin Exp Immunol, 2001,125(2): 237-244.
  • 10[6]Hogihara M, Lic, Gansuvd B, et al. Extensive and long-term ex vivo production of dendritic cells from CD34+ umbilical cord blood bone marrow cells by novel culture system using mouse stroma[J]. J Immunol Mothods, 2001, 253(1-2): 45-55.

共引文献4

同被引文献23

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部